Calidi Biotherapeutics Inc (CLDI)
0.242
+0.01
(+3.60%)
USD |
NYAM |
May 16, 16:00
0.2464
0.00 (0.00%)
After-Hours: 20:00
Calidi Biotherapeutics Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -22.31M |
December 31, 2022 |
Date | Value |
---|---|
September 30, 2022 | -9.605M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-22.31M
Minimum
Sep 2023
-9.605M
Maximum
Sep 2022
-15.96M
Average
-15.96M
Median
Free Cash Flow (Quarterly) Benchmarks
Minerva Neurosciences Inc | -6.094M |
Viking Therapeutics Inc | -6.134M |
CytomX Therapeutics Inc | -26.16M |
Genprex Inc | -4.974M |
Janux Therapeutics Inc | -15.03M |